ENTRY       D05866                      Drug
NAME        Sodium oxybate (USAN);
            Sodium gammahydroxybutyrate;
            Xyrem (TN)
PRODUCT     LUMRYZ (Avadel CNS Pharmaceuticals)
            XYREM (Jazz Pharmaceuticals)
  GENERIC   SODIUM OXYBATE (Amneal Pharmaceuticals NY LLC)
            SODIUM OXYBATE (Hikma Pharmaceuticals USA)
FORMULA     C4H7O3. Na
EXACT_MASS  126.0293
MOL_WEIGHT  126.0863
CLASS       Neuropsychiatric agent
             DG02030  Anesthetics
              DG02027  General anesthetics
REMARK      ATC code: N01AX11 N07XX04
            Chemical structure group: DG00798
            Product (DG00798): D05866<US>
            Product (mixture): D12131<US>
EFFICACY    Anesthetic (adjunct)
  DISEASE   Narcolepsy [DS:H01293]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N01 ANESTHETICS
               N01A ANESTHETICS, GENERAL
                N01AX Other general anesthetics
                 N01AX11 Sodium oxybate
                  D05866  Sodium oxybate (USAN) &lt;US&gt;
              N07 OTHER NERVOUS SYSTEM DRUGS
               N07X OTHER NERVOUS SYSTEM DRUGS
                N07XX Other nervous system drugs
                 N07XX04 Sodium oxybate
                  D05866  Sodium oxybate (USAN) &lt;US&gt;
            USP drug classification [BR:br08302]
             Sleep Disorder Agents
              Wakefulness Promoting Agents
               Sodium Oxybate
                D05866  Sodium oxybate (USAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG02030  Anesthetics
               DG02027  General anesthetics
                DG00798  Hydroxybutyric acid
                 D05866  Sodium oxybate
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D05866
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D05866
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D05866
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D05866
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG02030  Anesthetics
               DG02027  General anesthetics
                DG00798  Hydroxybutyric acid
DBLINKS     CAS: 502-85-2
            PubChem: 47207527
            LigandBox: D05866
            NIKKAJI: J6.207C
ATOM        8
            1   O1a O    14.4900  -16.5200
            2   C1b C    15.6800  -17.2200
            3   C1b C    16.9400  -16.5200
            4   C1b C    18.1300  -17.2200
            5   C6a C    19.3200  -16.5200
            6   O6a O    20.5800  -17.2200 #-
            7   O6a O    19.3200  -15.1200
            8   Z   Na   22.5400  -17.2200 #+
BOND        6
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 1
            6     5   7 2
///
